Primrose Bio

Primrose Bio develops and licenses manufacturing technologies for nucleic acids and proteins used in therapeutics and vaccines. Their offerings include improved enzymes for mRNA manufacturing, a validated production system for complex proteins, and a conjugate vaccine carrier protein. They aim to solve complex drug manufacturing and design challenges, partnering with leading pharmaceutical companies.

Buy Funded Startups lists

Funding Round: Equity

Funding Amount:

Date: 17-Jun-2024

Investors: 1315 Capital

Markets: Biotechnology, Pharmaceuticals, Biomanufacturing, Drug Delivery

HQ: San Diego, California, United States

Founded: 2023

Website: https://www.primrosebio.com/

LinkedIn: https://www.linkedin.com/company/primrose-bio

Twitter: https://twitter.com/PrimroseBio

Instagram: